Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...
Diabetes is a chronic, progressive disease characterized by elevated blood glucose levels. Diabetes can lead to complications such as cardiovascular disease, damage to eyes, kidneys and nerves, and premature death. Globally, more than 400 million adults live with diabetes, and diabetes directly caused 1....
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabète de type 2,
Diabète,
Marqueurs biologiques/sang,
Glycémie/métabolisme,
Angiopathies diabétiques/prévention et contrôle,
Fructosamine/sang,
Hémoglobine glyquée/métabolisme,
Hypoglycémiants/usage thérapeutique,
Espérance de vie,
Préférence des patients,
Soins centrés sur le patient,
Hémoglobine glyquée,
Hypoglycémiants
Entregar recomendaciones para apoyar a los equipos de salud en la toma de decisiones clínicas respecto del tratamiento farmacológico en pacientes adultos con diagnóstico de Diabetes Mellitus tipo
2, basadas en la mejor evidencia científica disponible y el consenso de expertos....
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Glycémie,
Association thérapeutique,
Diabète de type 1,
Diabète de type 2,
Régime pour diabétique,
Surveillance des médicaments,
Endocrinologie,
Hyperglycémie,
Hypoglycémie,
Insuline/usage thérapeutique,
Pompes à insuline,
Surveillance électronique ambulatoire,
Éducation du patient comme sujet,
Médecine de précision,
Diabète de type 1/traitement médicamenteux,
Diabète de type 2/traitement médicamenteux,
Diabète de type 1/thérapie,
Diabète de type 2/thérapie,
Hypoglycémiants/usage thérapeutique,
Hypoglycémiants/effets indésirables,
Insuline/effets indésirables
